The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19
François Danion(Hôpitaux Universitaires de Strasbourg), Yves Hansmann(Hôpitaux Universitaires de Strasbourg), Charlotte Kaeuffer(Université de Strasbourg), Marion Fourtage, Yvon Ruch(Hôpitaux Universitaires de Strasbourg), J. Müller(Hôpitaux Universitaires de Strasbourg), Thierry Nai, Nicolas Lefèbvre(Hôpital Civil, Strasbourg), Valentin Greigert(Centre Hospitalier Universitaire de Reims)
Cited by 4
Related Papers
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
|EBioMedicine|2021|239
Coagulase-Negative Staphylococci Pathogenomics
|International Journal of Molecular Sciences|2019|219
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth
|American Journal of Obstetrics and Gynecology|2020|197